News Center
Welcome to the News Center, 
please read the latest news and activities of Aktin.
CPHI China Shanghai 2027, from Jun.16-18, Booth No.: 11C79
2026-10-09


2027 marks the 25th anniversary of CPHI China. To celebrate this milestone year, the exhibition will officially relocate to the National Exhibition and Convention Center (Shanghai) in Hongqiao, moving from its long-time venue at the Pudong New International Expo Centre.


As a premier manufacturer of natural ingredients, Aktin Chemicals, Inc. will be exhibiting at this landmark event.




Established in 2005, Aktin Chemicals, Inc. is driven and backed by our three proprietary technology platforms: Phytopower® Development Platform of Bioactive Molecules & Ingredients from Global Medicinal Plants, Aktinsyn® Technology Platform of Synthetic Chemistry, and Aktinbio® Development Platform of Biotechnology. We provide high quality products for global nutrition, personal care and pharmaceutical industries and CRO/CDMO solutions for APIs & FDF. With over two decades of dedicated industrial manufacturing of natural products and their derivatives, Aktin operates two R&D centers alongside non-GMP and GMP factories. Demonstrating our strict commitment to global standards, our operations are fully certified under ISO 9001, ISO 14001, ISO 45001, KOSHER, and HALAL.




AKNUTR®Nutrition
Based on modern nutritional science, we have established a comprehensive scientific system of dietary nutritional supplements. Relying on the global supply chain system, we select high quality raw materials and gather the nutritional essence from all over the world. With a strong R&D team and advanced R&D facilities, we provide high quality, diversified and sustainable nutritional ingredients and production solutions to our customers through continuous technological breakthroughs and innovations.


AKCOS®Personal Care
Leveraging over two decades of R&D and manufacturing expertise in natural products, and guided by the philosophy of “Natural, Safe, Efficient, and Sustainable,” AKCOS® utilizes advanced extraction, isolation, and purification technologies alongside green chemistry and biotechnology, to provide customers with natural personal care ingredients and tailored solutions, empowering product development and application innovation.
AKCOS®deeply integrates active botanical ingredients, skin barrier science, and contemporary formulation requirements. We offer end-to-end support ranging from ingredient selection and efficacy positioning to product concept design, enable them to cultivate sound and differentiated product strengths in line with the trends of Clean Beauty, efficacy-driven skincare and sustainable formulations.


AKTINPHARM®Pharmaceutical
LeveragingPhytopower®Phytopower® Development Platform of Bioactive Molecules & Ingredients from Global Medicinal Plants, Aktinsyn® Technology Platform of Synthetic Chemistry, and Aktinbio®Development Platform of Biotechnology,,AKTINPHARM® offers integrated CRDMO services to global pharmaceutical enterprises, biotech companies, and Marketing Authorization Holders (MAHs). Our end-to-end capabilities span drug discovery, API process development, CMC studies, formulation development, regulatory documentation support, and commercial manufacturing.


AKTINPHARM® focuses on natural drugs, small-molecule APIs, peptides, ADC linker-payloads, and oligonucleotide drugs/LNP delivery materials. By embedding rapid early-stage R&D, robust process development, in-depth quality studies, and seamless regulatory compliance throughout the entire product lifecycle, we empower our clients to accelerate their transformation from proof-of-concept to IND/IMPD filings and from clinical supplies to commercial manufacturing.
Small Molecules & Natural Products:From Drug Discovery to Commercial APIs.
Peptide Therapeutics:Full-Chain Development Capabilities for Complex Modalities.
ADC Linker-Payloads: Controlled Development and Manufacturing of Highly Potent Molecules.
Oligonucleotide Therapeutics & LNP Delivery Materials: Crucial Enablers for RNA Therapeutics.


AKTINPHARM®integrates discovery, process development, analytics, formulation development, regulatory support, and manufacturing into a unified technological pipeline for synchronized advancement. Through flexible FTE and FFS collaboration models, we support full-scale development needs ranging from non-GMP R&D samples to GMP clinical and commercial supply, as well as from lab-scale and pilot-scale up to commercial manufacturing, catering to our clients' differentiated demands for speed, cost and regulatory compliance at varying stages.




To schedule a one-on-one meeting in advance, please feel free to contact us.

Cart
TotalProducts
Request Quote
  • China
  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Central African Republic
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Côte d'Ivoire
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor (Timor-Leste)
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Greece
  • Grenada
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • South Korea
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar (Burma)
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sri Lanka
  • Sudan
  • South Sudan
  • Suriname
  • Sweden
  • Switzerland
  • Syria
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates (UAE)
  • United Kingdom (UK)
  • United States (US)
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Yemen
  • Zambia
  • Zimbabwe
  • Beijing-Beijing
  • Tianjin-Tianjin
  • Hebei-Shijiazhuang
  • Shanxi-Taiyuan
  • Inner Mongolia-Hohhot
  • Liaoning-Shenyang
  • Jilin-Changchun
  • Heilongjiang-Harbin
  • Shanghai-Shanghai
  • Jiangsu-Nanjing
  • Zhejiang-Hangzhou
  • Anhui-Hefei
  • Fujian-Fuzhou
  • Jiangxi-Nanchang
  • Shandong-Jinan
  • Henan-Zhengzhou
  • Hubei-Wuhan
  • Hunan-Changsha
  • Guangdong-Guangzhou
  • Guangxi-Nanning
  • Hainan-Haikou
  • Chongqing-Chongqing
  • Sichuan-Chengdu
  • Guizhou-Guiyang
  • Yunnan-Kunming
  • Tibet-Lhasa
  • Shaanxi-Xi'an
  • Gansu-Lanzhou
  • Qinghai-Xining
  • Ningxia-Yinchuan
  • Xinjiang-Urumqi
  • Hong Kong-Hong Kong
  • Macao-Macao
  • Taiwan-Taipei